The effect of imipramine on the amount of mRNA coding for rat dopamine D2 autoreceptors

European Journal of Pharmacology

Volumn 337, Issue 2-3, 1997, Pages 291-296

  Dziedzicka Wasylewska, Marta ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Dopamine D2 autoreceptor; Imipramine; mRNA; Rat; Ventral tegmental area

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE AUTORECEPTOR; IMIPRAMINE; MESSENGER RNA; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FOREBRAIN; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; VENTRAL TEGMENTUM;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; AUTORECEPTORS; IMIPRAMINE; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 0030690443     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01286-7     Document Type: Article

References (35)

1. Antelman, S.M., Chiodo, L.A., De Giovani, L.A., 1982. Antidepressants and dopamine autoreceptors: Implications for both a novel means of treating depression and understanding bipolar illness. In: Costa, E., Racagani, G. (Eds.), Typical and Atypical Antidepressants. Raven Press, New York, NY, pp. 121-146.
2. 2 dopamine receptor cDNA. Nature. 336:1988;783-787.
3. Chiodo L.A., Antelman S.M. Electroconvulsive shock: Progressive dopamine autoreceptor subsensitivity independent of daily drug treatment. Science. 210:1980;799-801.
4. Chiodo L.A., Antelman S.M. Repeated tricyclics induce a progressive dopamine autoreceptors subsensitivity independent of daily drug treatment. Nature. 287:1980;451-454.
5. Civelli O., Bunzow J.R., Grandy D.K., Zhou Q., Van Tol H.H.M. Molecular biology of the dopamine receptors. Eur. J. Pharmacol. 207:1991;277-286.
6. 3H ]SCH 23390 binding and DA-sensitive adenylate cyclase in the limbic system Eur. J. Pharmacol. 167:1989;299-303.
7. Dziedzicka-Wasylewska M., Rogoż R. The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and ventral tegmentum of the rat. J. Neural Transm. Gen. Sect. 102:1995;221-228.
8. Dziedzicka-Wasylewska M., Maćkowiak M., Fijał K., Wedzony K. Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. J. Neural Transm. 103:1996;765-776.
9. 2 dopamine receptors in the rat brain. J. Neural Transm. 104:1997;515-524.
10. Herve D., Simon H., Blanc G., Lisoprawski A., Le Moal M., Glowinski J., Tassin J.P. Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat. Neurosci. Lett. 15:1979;127-133.
11. Herve D., Simon H., Blanc G., Le Moal M., Glowinski J., Tassin J.P. Opposite changes in dopamine utilization in the nucleus accumbens and the frontal cortex after electrolytic lesion of the median raphe in the rat. Brain Res. 216:1981;422-428.
12. Herve D., Blanc G., Glowinski J., Tassin J.P. Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat. Brain. Res. 237:1982;510-516.
13. Jongen-Rêlo A.L., Docter G.J., Jonker A.J., Vreugdenhil E., Groenewegen H.J., Voorn P. Differential effects of dopamine depletion on the binding and mRNA levels of dopamine receptors in the shell and core of the rat nucleus accumbens. Mol. Brain Res. 25:1994;333-343.
14. 2 receptors. J. Pharm. Pharmacol. 41:1989;555-558.
15. 3H ]SCH-23390 binding sites in the rat striatum and limbic system Eur. J. Pharmacol. 139:1987;163-169.
16. Maj J. Central effects following repeated treatment with antidepressant drugs. Pol. J. Pharmacol. Pharm. 36:1984;87-100.
17. 2 receptors in the rat brain Eur. J. Pharmacol. 304:1996;49-54.
18. 2 receptor binding in the rat brain and pituitary: An in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10:1990;2587-2600.
19. Martin-Iverson M.T., Leclere J-F., Fibiger H.C. Cholinergic-dopaminergic interactions and the mechanism of action of antidepressants. Eur. J. Pharmacol. 94:1983;193-201.
20. 2 receptor gene expression in brain. Biol. Psychiatry. 30:1991;995-1007.
21. 2 dopamine receptor mRNA in rat brain. Neuropsychopharmacology. 5:1991;231-242.
22. 2 receptor in the rat brain by in situ hybridization histochemistry. Proc. Natl. Acad. Sci. USA. 87:1989;6723-6727.
23. 2 dopaminergic receptors detected by in situ hybridization histochemistry in rat brain. FEBS Lett. 255:1989;335-339.
24. Nielsen J.A. Effects of chronic antidepressant treatment on nigrostriatal and mesolimbic dopamine autoreceptors in the rat. Neurochem. Int. 9:1986;61-67.
25. Oades R.D., Halliday G.M. Ventral tegmental (A 10) system: Neurobiology. 1. Anatomy and connectivity. Brain Res. Rev. 12:1987;117-165.
26. Palkovits, M., Brownstein, M.J., 1988. Maps and Guide to Microdissection of the Rat Brain. Elsvier, Amsterdam.
27. Randrup, A., Munkvad, I., Fog, R., Gerlach, J., Molander, L., Kjelberg, B., Scheel-Kruger, J., 1975. Mania, depression and brain dopamine. In: Essman, W.B., Valzelli, L. (Eds.), Current Developments in Psychopharmacology. Spectrum, New York, NY, pp. 206-248.
28. Roth R.H. CNS dopamine autoreceptors: Distribution, pharmacology and function. Ann. N.Y. Acad. Sci. 430:1984;27-53.
29. Roth, R.H., Wolf, M.E., Deutch, A.Y., 1987. Neurochemistry of midbrain dopamine systems. In: Meltzer, H.Y. (Ed.), Psychopharmacology: The Third Generation of Progress. Raven Press, New York, NY, pp. 81-94.
30. Serra G., Argiolas A., Klimek V., Fadda F., Gessa G.L. Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity. Life Sci. 25:1979;415-424.
31. Serra G., Argiolas A., Fadda F., Gessa G.L. Hyposensitivity of dopamine 'autoreceptors' induced by chronic administration of tricyclic antidepressants. Pharmacol. Res. Commun. 12:1980;619-624.
32. Waldmeier P.C. Effects of chronic antidepressant treatment on pre- and post-synaptic dopaminergic mechanisms. A short review of the literature and some complementary experiments. Pol. J. Pharmacol. Pharm. 36:1984;201-216.
33. 2 receptor mRNA in rat brain. FEBS Lett. 253:1989;207-213.
34. Wolf M.E., Roth R.H. Autoreceptors regulation of dopamine synthesis. Ann. N.Y. Acad. Sci. 604:1990;323-343.
35. 1 dopamine receptors. Nature. 347:1990;76-80.